The Medical Advisor

By OneDayMD | Updated June 2026 | Editorial review and synthesis of clinical, veterinary, and patient-reported data ⚠️ Medical Disclaimer: DMSO (dimethyl sulfoxide) is FDA-approved only for intravesical treatment of interstitial cystitis. Ophthalmic (eye) use is off-label and experimental. This article synthesizes historical clinical data, veterinary research, animal studies, and patient-reported outcomes — most of which lack modern randomized controlled trials. Self-experimentation on the eyes carries real risk including infection, irritation, and contamination. Always obtain a formal diagnosis and consult an ophthalmologist before pursuing any off-label eye treatment. This article is for educational purposes and does not constitute individual medical advice. 📋 Table of Contents — Jump to a Category 1. How DMSO Works in the Eye 2. Category: Corneal & Surface Disorders 3. Category: Lens & Structural Disorders (Cataracts, Floaters) 4. Category: Re...

Abstract Background: Stage 4 cancer — defined by metastatic spread beyond the original tumor site — has a poor prognosis with conventional treatment alone. There is growing interest in repurposed antiparasitic drugs such as ivermectin , fenbendazole , and mebendazole for potential antineoplastic effects. Preclinical research suggests mechanisms including disruption of oncogenic signaling pathways and inhibition of cancer cell proliferation and survival, but controlled clinical evidence in humans remains limited. Objective: To summarize and characterize a large compilation of anecdotal clinical case reports describing the use of ivermectin, fenbendazole, and mebendazole in individuals with Stage 4 cancers (various tumor types) and to highlight reported outcomes and therapeutic contexts. Methods: Over 320 individual case reports were aggregated from public sources — predominantly social media posts, practitioner-shared testimonials, and independently published patient narratives....